Site Search
Company Search
Get Quote
The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™
SeriousTradersSpotlight Company
VERAXA Biotech AG (NASDAQ: VRXA)
Investment Considerations VERAXA is advancing a diversified oncology pipeline spanning monoclonal antibodies, antibody-drug conjugates, bispecific ADCs and proprietary BiTAC-based therapeutic formats across multiple cancer indications. The company’s proprietary BiTAC platform is designed to conditionally activate therapeutic activity at tumor sites, with the goal of improving target specificity while reducing off-tumor toxicity. Through its focus on … Continue reading “VERAXA Biotech AG (NASDAQ: VRXA)”
Latest Press Releases
Filter Releases
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |
SeriousTraders is part of the IBN (InvestorBrandNetwork). Other brands within the investor brand network include:
Interested in a live, online demonstration?
SeriousTraders is powered by IBNAi
Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.
Copyright © .